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Purpose: Mechanisms by which fibroblast networks between stromal lamellae are laid in the corneal stroma are far from
clear. We have investigated the role of vascular endothelial growth factor receptors (VEGFRs) by in vitro studies in the
human corneal network formation obtained from donors whose ages ranged from 19 to 89 years.
Methods: Corneal fibroblasts were prepared from cornea donations. The functional properties of these cells to form
networks were analyzed using a semi solid matrix (substratum) of Matrigel™. The presence of VEGF receptor-1
(VEGFR-1) and the functionality in these fibroblasts were investigated using immunofluorescence, molecular analysis
(gene microarray, reverse transcription polymerase chain reaction [RT–PCR] and VEGFR siRNA transfections), and cell
culture.
Results: Corneal fibroblasts from 61 donors were classified into two groups according to whether they formed (82%) a
reticulum on Matrigel™ or not (18%). By RT–PCR and immunofluorescence analysis, we showed that corneal fibroblasts
expressed VEGFR-1 (mRNA and protein). Further, cell culture analysis revealed that only the network (reticulum) forming
corneal fibroblast expressed VEGFR-1 in contrast to non network-forming fibroblasts. Use of inhibitors such as VEGFR-1
siRNA transfection or neutralizing antibody (Avastin™) indicated that VEGFR-1 was essential to the formation of the
corneal network in vitro.
Conclusions: The cell reticulum formation seemed to be directly related to the expression of VEGFR-1 in the corneal
fibroblast, and this expression decreased with age. The decrease in VEGFR-1 expression is probably related to the
diminution of autocrine functions, which may alter the overall tissular homeostasis. This may culminate in the gradual
development of poor vision, which is observed in certain pathologies and in aging individuals.
The  cornea  is  a  highly  differentiated  tissue,  rich  in
extracellular  matrix  (ECM)  synthesized  by  its  cell
constituents. The corneal matrix is characterized by a well-
defined  supramolecular  structure  that  ensures  the  dual
function of the cornea, transparency as well as inner-eye tissue
protection. ECM disorders have been associated with various
eye diseases such as corneal macular dystrophy and Marfan’s
syndrome.
The human corneal stroma is a stacking of collagenous
lamellae.  They  are  colonized  with  keratocytes  (quiescent
cells) or following wound healing, with corneal fibroblasts or
myofibroblasts  (activated  cells  derived  from  keratocytes)
[1-3]. Several investigations have shown that the arrangement
of  keratocytes  within  the  corneal  stroma  is  an  essential
mechanism  in  the  maintenance  of  corneal  transparency.
Scanning electron microscopy has revealed a network of flat
cells with many small dendritic bifurcations in the rat cornea
[4].  Studies  on  rabbit  and  human  cornea  using
immunocytochemistry [5,6] and electron microscopy [7-9]
Correspondence to: Dr. Massoud Mirshahi, UMRS 872, Centre de
Recherches des Cordeliers, Faculté de Médecine Paris VI, 15 rue de
l’Ecole de Médecine, 75006, Paris, France; Phone: 00 33 1 42 34 69
31; FAX: 00 33 1 43 25 63 44; email: massoud.mirshahi@upmc.fr
have  described  the  existence  of  gap  junctions  between
keratocytes.  Flat  sections  of  the  cornea  show  that  the
fibroblasts  have  long  branching  processes  or  digitations,
which extend in several directions from the cell body and
establish contacts with similar processes of other cells in the
vicinity. According to several recent reports [10], these cells
appear  to  form  a  syncytium-like  structure.  This  however
contradicts earlier observations by others who used electron
micrographs, which showed the presence of almost a 200 Å
wide  intercellular  space  separating  these  cells  [11].  The
structural  morphology  of  intercellular  connections  of  the
corneal fibroblast was shown in flat sections of the corneal
stroma. It reveals the existence of a functional circuit of a
communication network between keratocytes [10]. However,
knowledge of the detailed mechanisms involved in the corneal
fibroblast network formation still eludes us. We have been
interested in the process of corneal fibroblast reticulation for
a few years now and have tried to further our understanding
through biochemical and cell biology studies. The fibulins, a
family of the ECM proteins, were characterized by our group
recently for their implication in the reticulation of organ shape
and stromal cell motility [1].
Due to its avascularity, the cornea has not only served as
the principal in vivo model system for studying angiogenesis
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1997but also as a convenient model for vascular endothelial growth
factor  (VEGF)  and  vascular  endothelial  growth  factor
receptor  (VEGFR)  signaling  pathways  in  several
physiopathological disorders [12].
VEGF  encompasses  a  family  of  structurally  related
proteins that include PlGF (placental-derived growth factor),
VEGF-A, VEGF-B, VEGF-C, VEGF-D, and VEGF-E. The
VEGF receptor family in mammals contains three members,
VEGFR-1 (fms-like tyrosine kinase-1 or flt-1), VEGFR-2
(kinase insert domain containing receptor/fetal liver kinase-1
or KDR/flk1), and VEGFR-3 (fms-like tyrosine kinase-4 or
flt-4) in addition to a co-receptor, NRP1 (neuropilin). These
factors directly participate in the genesis of blood capillaries
and lymphatic vessels [13-18].
It has been shown that corneal wound healing requires
the action of several angiogenic factors that include VEGF
and  b-FGF  (basic  fibroblast  growth  factor)  [19-21].  The
circulating soluble receptors, VEGFR-1 and VEGFR-3, play
a crucial role in the avascularity of the cornea. It acts by
binding free VEGF thereby making it unavailable for binding
to receptors on cell membranes [22,23].
Knowledge regarding the role of VEGF, the mechanisms
underlying corneal stromal cell integrity, and the complex
inter-cellular  network  formation  is  still  very  scant.  Our
laboratory  has  been  interested  in  understanding  the
complexity involved in corneal integrity and has undertaken
several lines of research aimed at it for the past few years. In
the present study, we focus on the role of VEGFR-1 in the
human  corneal  stromal  fibroblast  network  organization  in
vitro.
METHODS
Isolation  and  primary  culture  of  corneal  stromal  cells:
Human corneas were obtained from the “Banque Française
des yeux” after informed consent of the donors in agreement
with the revised rules of the Helsinki Protocol. Pieces of
cornea 2–3 mm2 in size were gently scratched to remove
epithelial cells. The corneal pieces were seeded on 24 well
plates containing Dulbecco’s Modified Eagle’s Medium:F12
(DMEM/F12; PAA, Mureaux, France) supplemented with
10%  fetal  calf  serum  (FCS),  penicillin  (100  U/ml),  and
streptomycin (100 µg/ml; PAA) and incubated at 37 °C in a
humidified  atmosphere  containing  5%  CO2.  Non-adherent
cells were removed and discarded after three days and the
culture dishes were washed with 1× phosphate buffer saline
(1× PBS; PAA). After an additional week in culture, some
cells began to spread out of the corneal explants. These cells
were primary corneal stromal cells and were detached with
trypsin  treatment  (PAA)  for  15  min.  The  cells  were
centrifuged,  and  the  pellet  was  washed,  resuspended,  and
seeded in the same complete medium for incubation for two
weeks in six-well plates (4×104 cells/cm2) in a humidified
atmosphere containing 5% CO2 at 37 °C. Samples were taken
and  used  for  experiments  from  the  first  passage  onwards
through the sixth.
Wound healing test: Motility and adhesion were analyzed on
cells  grown  to  80%  confluency  in  24  well  culture  dishes
coated with “Attachment Factor” (PAA). Then, four scars/
wounds (two vertical and two horizontal) were made using a
blunt glass tip. The dishes were then incubated in a DMEM/
F12 medium containing only 2% FCS, and triplicate dishes
were assigned for (a) the control, (b) with Avastin (10−7 M),
(c) with VEGF-A (100 ng/ml), and (d) with VEGF-C (100 ng/
ml). In the presence of 2% FCS, cell proliferation did not
occur, but cell viability was unaffected. The number of cells
that  migrated  into  the  wound  track  were  counted  during
incubation at intervals of 9 h, 18 h, 24 h, 48 h, and 72 h and
the mean number of cells computed (n=4).
Immunocytochemistry: One million cells were cultured for 24
h in glass chamber slides (Labtek®; Nunc, Naperville, IL) in
complete DMEM/F12. Cells were washed with a serum-free
medium and fixed for 15 min with 3% paraformaldehyde in
1× PBS. After three washes with PBS, cells were further
incubated for 20 min with 1% (w/v) bovine serum albumin
(BSA; Sigma-Aldrich, St Louis, MO) to avoid non-specific
binding. Cells were exposed to VEGFR-1 antibody for 1 h at
4 °C. After three washes with PBS, cells were treated with
anti-goat secondary biotinylated antibody for 1 h at 4 °C
(1:100 dilution). Cells were washed twice in PBS-BSA and
exposed to Streptavidin-Fluorescein (Sigma-Aldrich) for 45
min at 4 °C. The antibody fluorescence was observed on slides
using  a  Nikon  fluorescence  microscope  (Nikon,  Paris,
France).
Matrigel™ assays: The cell motility and cell-cell contacts
were assessed on Matrigel™, a natural murine fibrosarcoma
extracellular  matrix  (BD  Biosciences,  San-Jose,  CA).
Matrigel™ provides a physiologically relevant environment
for studies of cell morphology, migration, and invasion as
cultures  grown  on  top  of  it  presents  a  two-dimensional
situation for cellular network formation. A 96 well microplate
was coated with 35 µl of Matrigel™. After 1 h at 37 °C, 104
cells  in  200  µl  of  DMEM:F12  and  VEGF  (100  ng/ml;
PromoCell GmbH, Heidelberg, Germany) were seeded into
each  well.  Culture  cells  were  observed  using  an  inverted
microscope, and cell-cell contacts (intercellular junctions) as
well  as  tubular  reticulum  formation  were  counted  at  3  h
intervals and the results plotted as a histogram.
Analysis  by  gene  array:  The  gene  expression  patterns  of
corneal primary culture cells and human corneal fibroblasts
immortalized  by  SV40  T  antigen  transfection  [24]  were
analyzed  and  compared  by  a  two-color  topic-defined
microarray  (PIQOR  Microarray,  Miltenyi  Biotec  GmbH,
Bergish Galdbach, Germany) as described below. Briefly,
5×106 cells each (primary corneal culture cells as well as
immortalized corneal fibroblasts) were lysed in the Trizol®
reagent (Invitrogen, Carlsbad, CA) and shipped to Miltenyi
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1998Biotec GmbH in dry ice. Total RNA was extracted, reverse
transcribed, amplified, and fluorescence coupled with Cy3
(primary  culture  cells)  or  Cy5  (immortalized  corneal
fibroblasts) and then hybridized on PIQORTM microarrays.
The  capture  of  images  and  signal  quantification  were
performed by ScanArrayLite (Packard Bioscience, Billerica,
MA) and ImaGene software Version 4.1 (BioDiscovery, Los
Angeles, CA). Local background was subtracted to obtain net
signal intensity, and the Cy5/Cy3 ratios were calculated. The
results were analyzed by analysis of variance (ANOVA) test,
and the mean ratios of quadruplicate spots were normalized
using locally weighted linear regression by LOWESS (locally
weighted scatter plot smoothing) normalization method. Only
genes displaying net signal intensity twofold higher than the
mean background were considered significant and used for
further  analysis.  The  products  of  microarray  consisted  of
genes related to cytokines, interleukins, and growth factors.
Transfection  protocols:  Primary  fibroblast  cultures  were
prepared as described above and used when they attained 80%
confluence.  DMEM:F12  complete  medium  was  removed
Figure 1. Network formation by corneal
fibroblasts on Matrigel. Type-1(A) and
type-2  (C)  corneal  fibroblasts  were
seeded  on  matrigel  and  photographed
before incubation, representing time 0.
The  same  plates  were  photographed
after 2 h of incubation. B (type-1 corneal
fibroblast)  shows  cell  elongation  and
beginning  of  network  formation
whereas D (type-2 fibroblast) shows no
network formation, and resembles the
unincubated controls at time 0.
TABLE 1. GENE ARRAY ANALYSIS.
Gene name UniGene code Gene array analysis
VEGF
VEGFA Hs.73793 positive
VEGFB Hs.78781 positive
VEGFC Hs.435215 not tested
VEGFD Hs.113922 positive
VEGFE not tested
PlGF Hs.252820 negative
VEGF receptors
VEGFR-1 Hs.654360 positive
VEGFR-2 Hs.479756 negative
VEGFR-3 Hs.646917 negative
VEGF co-receptors
NRP1 Hs.131704 positive
NRP2 Hs.471200 not tested
VEGF , VEGFR s and NRP  mRNA expression by human corneal fibroblast cells. Column 1indicates the names of different genes
that were tested by gene array. Column 2 indicates their corresponding UniGene code. Column 3 shows whether the gene was
positive or negative for mRNA expression.
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1999from each six-well plate containing adherent cells and washed
once with PBS. Cells were detached by Accutase® (PAA) and
resuspended to give a concentration of 105 cells per 100 µl.
In  the  transfection  assay,  the  siRNA-couple  (Qiagen,
Hilden, Germany) for each mRNA was tested along with a
control sample using scrambled siRNA to determine changes
in cell phenotype, if any. A second control was also done using
only the medium without siRNA.
To ascertain the best suited protocol for transfection of
our cells, we have tried three different methods.
Amaxa® transfection protocol—This is essentially an
electroporation  protocol  consisting  of  the  following:  One
million cells with 100 µl of Nucleofactor™ solution (Amaxa;
Lonza, Cologne, Germany) and 2 µg siRNA (for each sample)
was  mixed  in  Eppendorf  tubes  and  transferred  to  Amaxa
certified cuvettes at 37 °C. The manipulations were quick and
lasted  less  then  15  min  to  avoid  cell  mortality  and  thus
adversely affect efficiency of gene transfer. At the end of
electroporation,  500  µl  of  the  pre-warmed  DMEM:F12
containing serum at 37 °C was added to each cuvette. The cells
were seeded and incubated for 24 h in a humid atmosphere at
37 °C with 5% CO2.
Hiperfect® Qiagen protocol—The siRNA-couple was
diluted  (37.5  ng/100  μl)  in  serum  free-medium.  Three
microliters of HiPerfect transfection reagent (Qiagen) was
added to the diluted siRNA and mixed by vortexing. The
samples were incubated for 10 min at room temperature to
allow formation of transfection complexes. These complexes
were added onto 105 cells per 100 µl and incubated for 6 h at
room  temperature  after  which  300  µl  of  the  medium
containing 10% FCS was added in each well and incubated
further for 24 h in a humid atmosphere at 37 °C with 5%
CO2.
Nanofectin®  transfection  protocol—The  stock
solutions of siRNA and Nanofectin siRNA were used at room
temperature. Half a microgram of siRNA (i.e. 15 pmol) in
30 µl of serum free-medium was added to each well. Two and
a half microliters of Nanofectin (PAA) was added to siRNA
in 40 μl of serum free-medium in a second series of wells. The
two series of wells were incubated separately for 20 min at
room temperature after which the solutions from the first and
second series were pooled together giving a final volume of
70 μl for the siRNA nanocomplex mixture. This solution was
added drop-wise to 105 cells in 500 µl of medium with or
without FCS. The incubation continued at room temperature
for 6 h. Cells were pooled and centrifuged. The washed pellet
was  resuspended  for  another  24  h  incubation  in  a  humid
atmosphere at 37 °C with 5% CO2. At the end of the incubation
and for each transfection protocol tested, a viability test with
Trypan  Bleu®  (Sigma-Aldrich)  was  performed  and  the
number of living and dead cells was determined.
PCR  procedure:  Total  RNA  was  extracted  from  primary
corneal fibroblasts using Nucleospin RNA-II kit (Macherey-
Nagel, Hoerdt, France). Cells (5×106) were lysed at 0 °C, and
RNA and DNA were selected on the silicate membrane. DNA
was degraded directly on the silicate membrane using DNase
I for 15 min at room temperature. Following several washes,
total RNA was eluted with RNase free water and the integrity
of RNA verified on a 2% agarose gel (Sigma-Adrich) in 0.45%
ethidium  bromide  and  quantified  by  spectrometry  at  the
wavelength of 260–280 nm. One microgram of total RNA was
used for reverse transcription to create cDNA according to the
standard protocol. We used the following synthetic primers
(Eurobio, Paris, France): VEGFR-1 sense 5′-CAC CAA GAG
CGA CGT GTG-3′, antisense 5′-TTT TGG GTC TCT GTG
CCA G-3′ (196 bp) and β2microglobulin sense 5′-CCA GCA
GAG AAT GGA AAG TC-3′, antisense 5′-GAT GCT GCT
TAC ATG TCT CG-3′.
The reaction mixture consisted of 15 ng of cDNA and 2.5
units Taq polymerase (GibCo BRL, Paisley, UK), and the
amplification  was  performed  according  to  the  protocol
recommended by GibCo BRL. The melting temperature (Tm)
for VEGFR-1 and for β2microglobulin was 60 °C. Polymerase
chain reaction (PCR) products were analyzed on 2% agarose
gel electrophoresis in 0.45% ethidium bromide. The PCR
cycle number was normalized to the amount of human β2-
microglobulin cDNA product.
Statistical analysis: The Fischer test: statistical analysis was
performed using the modified FISHER test. The data was
expressed as standard error of the mean (SEM). A p value less
than 0.05 was considered statistically significant.
RESULTS
Network  formation  by  corneal  fibroblasts  on  Matrigel™:
Network  formation  of  corneal  fibroblasts  is  presented  in
Figure 1. Primary culture cells from 62 donors were seeded
on Matrigel™. Corneal cells from 51 donors (82%) organized
into  tubules  while  11  donors  (18%)  remained  dispersed
(unorganized).  These  results  suggest  that  the  corneal
fibroblasts from donors belong to two distinct categories and
can be classified into type 1 and type 2 according to whether
they form (Figure 1A,B) or do not form (Figure 1C,D) a
network on Matrigel™. Normally, after 2 h, cell network
formation starts, and cell-cell interaction lead to the formation
of a cell network as described in “Reticulogenesis” [25].
Gene array analysis: Table 1 indicates that corneal fibroblasts
in primary culture (n=4) or the immortalized cell line (n=1)
express VEGF-A, VEGF-C, VEGFR-1, and NRP1 mRNA but
not VEGFR-2, VEGFR-3, and VEGF-D mRNA. These results
were  also  confirmed  by  reverse  transcription  polymerase
chain reaction (RT–PCR) analysis using specific primers.
Demonstration of VEGFR-1 protein in corneal fibroblasts:
The  presence  of  VEGFR-1  was  determined  by
immunofluorescence. A significant level of VEGFR-1 was
expressed by type 1 donor fibroblasts (Figure 2A) whereas the
VEGFR-1 immunoreactivity was low in corneal fibroblasts of
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2000type  2  donors  (Figure  2C).  Anti-VEGFR-2  was  negative
(Figure 2B,D).
Induction  of  corneal  fibroblast  network  by  VEGF:  To
ascertain the role of VEGF receptors in the corneal fibroblast
network formation, two groups of cells, type 1 and type 2,
were studied. Figure 3 shows that the addition of exogenous
VEGF (100 ng/ml) significantly increased the number of cell
interconnections in only type 1 cells (Figure 3A,B). These
results also indicate that type 2 fibroblasts do not respond to
exogenous  VEGF  (Figure  3C,D).  The  number  of  tubules
formed on Matrigel™ at 3 h and 18 h is presented in Figure
3E.
Induction of corneal fibroblast migration by VEGF-A and
VEGF-C: As shown in Figure 4, cell motility and adhesion
were counted using the “wound healing assay” at 9 h, 18 h,
24 h, 48 h, and 72 h (arrows indicate the site of freshly created
scars). Figure 4A-E are micrographs after 24 h incubation
while Figure 4F-I are pictures taken after 72 h of incubation.
Figure 4B,F are untreated samples which serve as controls.
Exposure  of  culture  cells  to  VEGF-A  (Figure  4C,G)  and
VEGF-C  (Figure  4D,H)  significantly  increased  cell
migration . However, cell migration was adversely affected
when  an  anti-VEGF,  Avastin,  was  added  to  the  culture
medium (Figure 4E,I). Avastin-mediated inhibition clearly
suggests that the VEGFs play an important role in corneal
fibroblast cell motility. The quantitative analysis of the cell
number  in  different  conditions  is  presented  in  Figure  4.
Quantitative analysis as presented in the graph (Figure 4J)
clearly confirms the microscopic observations. The effect of
Avastin was noticeable already at 24 h, but at 72 h, cell
migration suffered markedly in its presence when compared
to controls. In the presence of VEGF-A and VEGF-B, the cell
number at 72 h increased 1.5 times as compared to the control
cultures, but it decreased 0.5 times instead with Avastin.
Behavioral  properties  of  cells  transfected  with  VEGFR
siRNA: Immunofluorescence studies presented in Figure 2
indicate that VEGFR-1 proteins are present in the human
corneal fibroblast type 1 whereas it is undetectable in type 2.
However,  both  types  are  negative  for  the  presence  of
VEFGR-2.
We compared three methods of cell transfection, namely
using: i) Amaxa electroporation, ii) Hiperfect® reagent, and
iii) Nanofectin®. Cell viability by trypan blue exclusion was
performed  at  time  0  h  and  found  to  be  above  95%.  We
observed that viability was remarkably different for the 3
different methods tested 24 h after transfection (15% of cell
viability with Amaxa electroporation, 85% with HiPerfect®,
and  81%  with  Nanofectin®).The  results  are  presented  in
Figure 6. We have used the Hiperfect® method for further
experiments because it gave us the best results.
The  plasticity  of  transfected  type  1  fibroblasts  was
analyzed  on  Matrigel™  in  parallel  with  control  cells.
Untreated  corneal  cells  (control)  readily  organized  into
Figure  2.  Demonstration  of  VEGFR1
protein  in  corneal  fibroblasts  by
immunofluorescence. The presence of
VEGFR1  was  investigated  using
antibodies  specific  to  VEGFR1  and
VEGFR2.  A:  Significant  levels  of
VEGFR1-specific fluorescence in type
1  donor  fibroblasts.  VEGFR1
immunoreactivity was undetectable in
type 2 donors cells (C). B (type -1) and
D (type-2) represent cells treated with
anti-VEGFR2  antibodies,  providing
negative controls.
Molecular Vision 2009; 15:1997-2007 <http://www.molvis.org/molvis/v15/a213> © 2009 Molecular Vision
2001
We have investigated the presence of VEGFR-1 mRNAs
in fibroblasts type 1 and type 2 by RT–PCR analysis. Type 1
fibroblasts express VEGFR-1 mRNA (Figure 5, slots B and
E) whereas type 2 do not (Figure 5, slots A, C, and D). We
also  transfected  VEGFR-1  specific  siRNA  into  type-1
fibroblasts, using as controls experience negative VEGFR-2
and VEGFR-3 siRNAs or a scrambled siRNA provided by
Qiagen.networks when grown on Matrigel™ substratum (Figure 7A).
Transfection  with  VEGFR-2  and  VEGFR-3  siRNAs  or
scrambled siRNA (results not shown), which were used as
controls as indicated above, gave results comparable to the
untreated control. In contrast, cell transfection by VEGFR-1
siRNA (Figure 7B) dramatically decreased cell motility and
network formation whereas VEGFR-2 siRNA (Figure 7C) and
VEGFR-3 siRNA (Figure 7D) did not significantly affect the
network formation.
In addition, the number of tubules formed by corneal
fibroblast cells transfected with the three different siRNAs
(VEGFR-1, VEGFR-2, and VEGFR-3) after 18 h of incubation
is presented in Figure 7E. These results confirm again that
VEGFR-1 inhibition (and to a much lesser extent VEGFR-2
and VEGFR-3 inhibition) adversely affects tubule forming
properties of corneal fibroblast type 1.
Our results show that the down-regulation of VEGFR-1
synthesis  also  adversely  affects  cell  motility  and  network
formation. Our data, therefore, suggests that VEGFR-1 is an
important  actor  in  the  functional  organization  of  corneal
stromal fibroblasts.
Age dependent decrease of VEGFR-1 expression: Statistical
analysis showed that the capacity of corneal fibroblasts to
form networks on Matrigel™ is directly related to the age of
the donors (Figure 8). Type 1 fibroblast cells predominated
the corneal stroma in young donors whereas with increasing
age, type 2 fibroblast cells begin to take over. In fact, the
70-90-year-old age group was composed of donors for type 2
fibroblast cells. Our results indicate that the expression of
VEGFR-1 decreases with age.
DISCUSSION
Cell  reticulation  of  stromal  fibroblasts  is  a  fundamental
requisite for lamellar organization in cornea formation. Events
that  hinder  this  physiologic  process  can  have  heavy
consequences.  One  sees  one’s  surroundings  through  the
corneal structure without even being aware that one is looking
Figure 3. Figure-3 Induction of corneal
fibroblast  network  by  VEGF.  The
addition of exogenous VEGF (100 ng/
ml), significantly increased the number
of cell inter-connections in only type 1
cells after 3 h (A) and after 18 h (B).
Type  2  fibroblasts  do  not  respond  to
exogenous VEGF after 3 h (C) and after
18 h (D). The number of tubules formed
on Matrigel counted after at 3 h and 18
h and are presented in E.
Molecular Vision 2009; 15:1997-2007 <http://www.molvis.org/molvis/v15/a213> © 2009 Molecular Vision
2002Figure 4. Corneal fibroblast migration induced by VEGF-A and VEGF-C as demonstrated by a wound healing assay: Upper panel: A shows a
photomicrograph of freshly created scar which is indicated as a space between the two arrows, which serves as a reference for observing cell
migration. B, C, D, and E are photomicrographs after 24 h incubation while F, G, H, and I are photomicrographs taken after 72 h of incubation.
B and F are untreated samples which serve as controls. C and G were treated with VEGF-A, while D and H were treated with VEGF-C. E
and I were plates exposed to Avastin. The number of cells migrating into the scar regions were counted in all samples at time 0, 9 h, 18 h, 24
h, 48 h, and 72 h of incubation and graph J was plotted.
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2003through a well organized and structured organ. Its architecture
and organization are primordial to its physiologic functions.
Large amounts of data have been generated to understand
corneal function in diseases and aging. However, much still
remains to be understood. For the last few years, we have been
focusing our research interest in understanding human corneal
functions and notably ECM-associated corneal disorders. In
a recently published work [1], we have provided evidence
regarding  the  role  of  the  fibulin  family  proteins  in  the
organization of supramolecular ECM structures of the cornea.
Another  major  finding  that  we  reported  concerns  the
production of protease type plasminogen activator (t-PA) and
their inhibitors (PAI) in the human cornea and the alteration
of  these  secretions  (t-PA  and  PAI)  in  Schnyder's  corneal
dystrophy [26,27].
In the present work, we have attempted to further our
current knowledge on the implication of growth factors in
stromal  networking  and  organization  of  the  cornea.  Our
results indicate that some of the corneal fibroblasts can form
cell-cell reticulation in vitro, which may be an indication of
what is happening in vivo. We can distinguish two cell types
(type 1 and type 2). Type 1 cells are the most abundant in
individuals up to nearly sixty years of age, whereas type 2 cells
make  their  appearance  with  increasing  age  when
physiological body functions are affected and vision begins
to diminish.
Cell type 1 properties and functions are intimately related
to  the  expression  of  growth  factor  receptor,  VEGFR-1.
Exposure to antagonist (Avastin) and siRNA abolishes the
capacity  of  these  fibroblasts  to  migrate,  establish
interdendritic  contacts,  and  organize  into  a  functional
reticulum  during  stromal  lamellae  formation.  The
proliferative  and  migratory  effect  as  well  as  tubule  and
junction  formation  can  be  enhanced  considerably  by
exogenous addition of VEGFR-1 to in vitro culture cells in
our Matrigel™ system. VEGFR-1 therefore has a preeminent
role  in  fibroblast  cell  migration,  interdendritic  contact
formation, and the functional organization of the reticulum in
stromal lamellae. These constitute a cascade of interrelated
events leading to the formation of a healthy and functional
cornea.
VEGFR-1 is a high affinity receptor for VEGF-A, VEGF-
B, and PlGF. On the other hand, VEGFR-2 is expressed in
neither type 1 or 2 cells and therefore is perhaps of no apparent
consequence in the structural and functional organization of
the cornea.
VEGFR-1 is also expressed in vascular endothelial cells
and  non-endothelial  cells  including  macrophages  and
Figure 5. VEGFR1 mRNAs detection in
fibroblasts of type 1 and type 2 by RT-
PCR. Slots B and E show that type 1
fibroblasts  express  VEGFR1  mRNA
whereas type 2 cells do not (slots A, C,
and  D).  β2-microglobulin  mRNA
served as an internal control.
Figure 6. Cell viability for each of the
three  methods:  electroporation,
Hiperfect,  and  Nanofectin.
Determination of cell viability at 0 h and
after  24  h  for  siRNA  transfection
experiments  using  electroporation,
Hiperfect,  and  Nanofectin.  The  result
was plotted as a histogram.
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2004monocytes [28], mesenchymal cells [29], and hematopoietic
stem  cells  [30].  VEGFR-1  signaling  is  involved  in  the
migration of monocytes/macrophages [31], and it has also
been shown that VEGFR-1 plays a role in PlGF-mediated
recruitment  of  hematopoietic  stem  cells  (HSCs)  from  a
quiescent state to a proliferative one in the bone marrow,
favoring differentiation, mobilization, and reconstitution of
hematopoiesis [32]. The addition of exogenous VEGF to cells
seeded on Matrigel™ clearly affected cell motility and contact
formation  besides  increasing  cell  proliferation.  Our
observation is in conformity and goes along with the results
obtained with the hematopoietic cell system by other authors
[25,28].
VEGFR-1  blocking  antibodies  have  been  shown  to
prevent migration but not proliferation of HUVEC (human
vascular endothelial cells) in response to VEGF-A, thereby
indicating the involvement of VEGFR-1 in endothelial cell
migration [33]. It has also been suggested that VEGFR-1-
mediated signaling preferentially modulate the reorganization
of actin via p38 MAPK (Mitogen-activated protein kinases)
whereas VEGFR-2 contributes to the reorganization of the
cytoskeleton by phosphorylating FAK (focal adhesion kinase)
and  paxillin  (a  focal  adhesion-associated  adaptor  protein)
[34].  Our  results  from  the  gene  array  show  that  these
molecules  are  constitutively  expressed  and  may  play  an
autocrine  or  paracrine  role  in  maintaining  hemostasis  of
corneal fibroblasts. Avastin, a humanized monoclonal VEGF
antibody,  blocks  cell  migration,  which  indicates,  though
indirectly, the autocrine function of constitutively expressed
VEGFs.
The results of the “wound healing” study confirm the
autocrine role of VEGFR-1 in cell type 1 in migration and
tubule formation. The decrease in VEGFR-1 expression is
related  to  the  diminution  of  the  autocrine  function  and
probably a progressive loss of cell multiplication and cell
renewal, which culminates in the appearances of type 2 cells
and the gradual development of poor vision.
In conclusion, the corneal fibroblast reticulations as seen
in vitro seem to be related to the level of VEGFR-1 expression,
and this expression decreases with age. This may also reflect
Figure  7.  The  plasticity  of  type  1
fibroblasts  transfected  with
VEGFR1,VEGFR2,  and  VEGFR3
siRNAs  as  demonstrated  on  Matrigel
after  18  h  of  incubation.  A:  Non
transfected  corneal  fibroblasts;  B:
transfected  with  VEGFR1  siRNA;  C:
transfected with VEGFR2 siRNA; and
D:  transfected  with  VEGFR3  siRNA.
The  number  of  tubules  per  field  was
counted and the mean was plotted as a
histogram (E).
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2005in vivo. Our observation is significant since in pathological
conditions or in age-related vision, diminution manipulations
of  VEGFR-1  expression  may  provide  a  novel  treatment
approach.  Restoring  VEGFR-1  function/expression  levels
may hold promises in treating stromal corneal pathologies in
the young as well as aging individuals. Development of an
artificial cornea for the vision deprived is a hope that needs to
be sustained through research initiatives. The present work is
a preliminary contribution toward achieving this goal.
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